BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

ActivBiotics

MISSIONActivBiotics is focused on the development and commercialization of antibacterials for the treatment of acute and chronic disease.



PRODUCT PORTFOLIO

ActivBiotics is developing rifalazil - a potent broad spectrum antibiotic that targets and inhibits the transcriptional machinery of bacteria. Previously studied in Phase I and IIA clinical trials, rifalazil is currently being planned for additional Phase II trials in several indications. In addition, ActivBiotics is owns a proprietary library of structurally related new chemical entities (NCEs).


Contact Details:
2 Oliver Street, 3rd Floor
Boston
MA
02109
United States of America
Tel:(617) 423 9995
Fax:(617) 423 9997
Email:info@activbiotics.com
WWW:

www.activbiotics.com/




Loading...

Recent Publications by ActivBiotics:

Efficacy of superoxide dismutase mimetic M40403 in attenuating radiation-induced oral mucositis in hamsters.
PURPOSE: M40403 is a small-molecule superoxide dismutase mimetic that has...
1st August, 2008
ActivBiotics, Inc., Lexington, Massachusetts, USA. Clin Cancer Res. 2008 Jul 1;14(13):4292-7.
DOI Direct Link
Determination of rifalazil in dog plasma by liquid-liquid extraction and LC-MS/MS: quality assessment by incurred sample analysis.
Incurred dog plasma samples were utilized for method quality assessment in...
4th March, 2008
ActivBiotics, Inc., 110 Hartwell Avenue, Lexington, MA 02421, USA. J Pharm Biomed Anal. 2007 Nov 30;45(4):616-24. Epub 2007 Sep 12.
DOI Direct Link
Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections.
Rifalazil is a benzoxazinorifamycin which inhibits bacterial DNA-dependent...
6th February, 2008
ActivBiotics, Inc., Lexington, Massachusetts 02421, USA. Arch Pharm (Weinheim). 2007 Oct;340(10):517-29.
DOI Direct Link
Determination of rifalazil, a potent antibacterial agent, in human plasma by liquid-liquid extraction and LC-MS/MS.
A sensitive assay for determination of rifalazil (also known as ABI-1648...
31st January, 2008
ActivBiotics, Inc., 110 Hartwell Avenue, Lexington, MA, USA. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 1;859(1):103-10.
DOI Direct Link
In vitro activity of novel rifamycins against gram-positive clinical isolates.
We describe novel rifamycins that have improved activity, compared with...
4th January, 2008
ActivBiotics, Inc., J Antibiot (Tokyo). 2007 Sep;60(9):572-6.

View more ActivBiotics research publications.

BioNews Results for ActivBiotics:

Spherics, Inc. Successful Bidder May Make NDA Submission
KOTA Territory News:  Aug 13 2008 5:00PM Matching: activbiotics
Spherics, Inc. Successful Bidder May Make NDA Submission
KLFY:  Aug 13 2008 4:39PM Matching: activbiotics
Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A
KRON4:  Aug 4 2008 11:45PM Matching: activbiotics
Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A
KOTA Territory News:  Aug 4 2008 7:02PM Matching: activbiotics
Targeting HDL in the Management of Mixed Dyslipidemia: Emerging Therapeutic Strategies for Cardiovascular Risk
Abstracts in Hematology and Oncology:  Jul 14 2008 9:22PM Matching: activbiotics
Promote your company here: BioNewsCast - Press Release Distribution

View more ActivBiotics news.

ActivBiotics Patents:

US Patent No.Title
7342011 Rifamycin analogs and uses thereof
7271165 Rifamycin analogs and uses thereof
7220738 Rifamycin analogs and uses thereof
7122525 Targeted therapeutics and uses thereof
7078399 Sulfhydryl rifamycins and uses thereof

View more ActivBiotics patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 278 times since April 2007, the link to the organisation's website has been followed 53 times

Search for more companies in Boston

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ActivBiotics
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.